Innovating Works

IGEN BIOTECH

Inactiva
ReaxPro: Software Platform for Multiscale Modelling of Reactive Materials and Processes IGEN BIOTECH participó en un H2020: Reactive process design has largely been based on trial-and-error experimentation and similarly, reactor design has utilised empirical kinet...
2018-12-12 - 2023-08-31 | Financiado
EPIGEN: EPIGEN A New Predictive Response Test for Non Small Cells Lung Cancer Treatment IGEN BIOTECH tramitó un H2020: H2020-SMEInst-2014-2015 EPIGEN test is a ready-to-use tool capable to lead the oncologist to the best Non Smal Cell Lung Cancer treatment, the most common subtype o...
2015-08-25 - 2015-10-31 | Financiado
MID-FRAIL-STUDY: A RANDOMIZED CLINICAL TRIAL TO EVALUATE THE EFFECTIVENESS OF A MULTI MODAL INTERVENTION IN OLDER PE... IGEN BIOTECH participó en un FP7: The prevalence of diabetes in people ≥ 65 years approaches 25% (40% of all patients with diabetes are > 65 years). This number will increase...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.